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Multivariate survival analysis with doubly-censored data:
application to the assessment of Accutane treatment for
brodysplasia ossicans progressiva
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1Department of Statistics; Massey University; Palmerston North; New Zealand
2Department of Applied Science; University of California; Davis CA 95616; U.S.A.
SUMMARY
Fibrodysplasia ossicans progressiva is a rare genetic disorder in which the joints of patients become
disabled by the formation of heterotopic bone. Data are available on the status of 11 joints of each of
21 patients before, during and after treatment with Accutane. These are compared with data obtained
by questionnaire from 40 untreated patients to determine the ecacy of the treatment. Both left- and
right-censoring are present in each group, which, together with the multivariate nature of the data and
the time-dependent treatment covariate, makes analysis dicult. We consider two alternative parametric
models for incorporating within-subject dependence: a marginal model and a frailty model. Both analyses
suggest that Accutane treatment is eective. We discuss and illustrate the dierences between the two
approaches. We also discuss the extent to which the conclusions are compromised by the observational
nature of the study. Copyright ? 2002 John Wiley & Sons, Ltd.
1. INTRODUCTION
Fibrodysplasia ossicans progressiva (FOP) is an extremely rare and disabling genetic dis-
order characterized by progressive heterotopic ossication of soft tissues, leading to the im-
mobilization of aected joints. Bone formation can be stimulated by blunt trauma, surgery,
intramuscular injection or aggressive physical therapy, but most often occurs spontaneously.
At present no eective prevention or treatment is known [1].
In 1992, 44 patient members of the International Fibrodysplasia Ossicans Progressiva
Association responded to a postal survey of the age at onset of heterotopic ossication at
each of 15 anatomic sites [2]. For each patient in the survey, and for each anatomic site,
the patient was asked to record the date at onset of heterotopic ossication. Right-censoring
occurred when a particular joint was uninvolved at the time of the survey: left-censoring
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when the patient replied that a joint was already involved but they could not provide the
date of onset. From the 660 onset times in the survey, 231 were right-censored and 41
left-censored.
Retinoids are a plausible family of therapeutic agents for FOP because of their ability to
inhibit dierentiation of mesenchymal tissue into cartilage and bone. An age-matched internal
control study was designed to determine the eectiveness of 13-cis-retinoic acid (Accutane)
in the prevention of new heterotopic lesions in patients. After nearly one year of attempted
recruitment, it proved impossible to assemble an internal age- and disease-severity-matched
control group. Most patients over 21 had severe symptoms and did not wish to receive
Accutane, whereas most under 21 had more mild manifestations of FOP and were unwilling
to receive a placebo. Because of this, and the extreme rarity of the condition, it was decided
to recruit FOP patients into a treatment group only and to use the survey data as an external
control.
Twenty-one patients who had FOP were recruited sequentially during an initial or follow-
up visit to the FOP clinic at the National Institute of Health. Eleven anatomic regions were
assessed in each of the 21 patients by clinical examination, plain roentgenograms and radionu-
clide bone scans. An anatomic region was considered to be involved if there was clinical,
roentgenographic or radionuclide evidence of orthotopic or heterotopic ossication anywhere
in that region. The regions thus assessed in the treatment group were the neck, spine, jaw,
right shoulder, left shoulder, right elbow, left elbow, right hip, left hip, right knee and left
knee; these regions were also included in the survey data from the external control, along with
right=left wrist and ankle. The duration of treatment ranged from four months to ten years,
with median three years and quartiles one and ve years. The total number of uninvolved
joints prior to treatment was 88; only two of these became involved during treatment, both
belonging to the same patient.
There are a number of problems in assessing the eectiveness of the treatment. The lack
of an internal control group may lead to bias, especially since the selection criterion and the
criterion for diagnosis of involvement of an anatomic region is dierent in each group. We
postpone discussion of this point until Section 5, where possible group dierences are analysed.
Our main focus of consideration is the multivariate nature of the data. The total number of
patients is too small for the eect of treatment on any single uninvolved joint to be estimated
with any precision, so it is necessary to examine all anatomic regions simultaneously and to
somehow account for the within-patient dependence. Thus the data are highly multivariate,
with 11 observations on each subject corresponding to the status of each of 11 anatomical
sites. The presence of both left- and right-censoring, and a time-dependent covariate, increase
the technical diculty of analysis.
There is now a large literature on multivariate survival analysis. The marginal model ap-
proach of Wei et al. [3] ts univariate models to the marginal distributions and uses Huber’s
sandwich estimator [4] to make joint inference about the regression parameters from each
model, with no attempt made to model the within-patient dependence. The frailty model ap-
proach, on the other hand, attempts a parametric model of this dependence by postulating
a patient-specic parameter, a ‘frailty’, to account for each patient’s particular susceptibility
to new events [5–8]. It is usual in both approaches to assume proportional hazards and to
model the baseline hazard functions non-parametrically, as in the Cox model, although the
interpretation of proportionality varies, applying to the marginals in the rst approach and
the conditional distributions given the frailty in the second. Parametric models for the hazard
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functions are also possible. Huster et al. [9] explicitly compared the two approaches in a para-
metric analysis of paired survival data, nding that the marginal approach was computationally
simpler but less ecient.
The commonly used partial likelihood approach cannot be used for our data because of the
double censoring. Several authors [10–12] have examined the estimation of semi-parametric
proportional hazard models with doubly-censored or interval-censored data, but time-dependent
covariates seem to present a special challenge in this context. Recent work by Goggins et al.
[13] applies the Cox model for an interval-censored time-dependent covariate to data which is
exact or right-censored. We have attempted to solve the combination of diculties in the FOP
data by using parametric versions of both a marginal model and a frailty model, which we
then compare. The advantage of a parametric approach here is the relative ease of handling
of dierent censoring patterns. Although our data contained no interval-censoring the methods
are easily extended to cover such cases.
In applications the multiple events are either homogeneous (same hazard structure) or het-
erogeneous. Our data set arguably has both types: some joints, such as the neck and jaw,
clearly have dierent baseline hazards whereas pairs such as right knee=left knee might be
expected to be the same. An additional complication is the small number of patient-years on
treatment, which together with the few observed failures during treatment makes a straight-
forward application of the robust variance in the marginal model invalid. We propose a
transformation which improves the performance of this method in such circumstances.
The paper is organized as follows. We rst discuss the modelling of the marginal distri-
butions, then in Section 3 investigate inference for the treatment eect using this marginal
model. In Section 4 we develop a frailty model and discuss its estimation. Possible group
dierences are investigated in Section 5 using both approaches. Finally, in Section 6 we com-
pare two approaches and discuss their implications for the use of Accutane in treating FOP.
Some of the statistical results from this paper were used in Zaslo et al. [14].
2. THE MARGINAL MODEL
Here we consider modelling the age Tij of the ith patient at the onset of involvement of
joint j. Ignoring for the moment the treatment eect and any other covariates, we observe
(tij; ij); i=1; : : : ; n where =0 indicates right-censoring (in which case Tij¿tij); =1 for
uncensored observations (Tij= tij) and =2 for left-censoring (Tij¡tij). Rocke et al. [15]
examined the marginal distributions for the control group using both Weibull models and
Turnbull’s non-parametric estimator [16]. Examples of the resulting survival curves, from the
control group survey data, are given in Figure 1. The Weibull model gives results similar to
the Turnbull estimates, and is more attractive since it can handle the time-dependent treatment
covariate relatively easily.
Adopting the Weibull model, we assume that Tij has a survival function Sj(·) given by
Sj(t)=P[Tij¿t]=e−(jt)
j
for the control group, and
S∗j (t)=P[Tij¿t]=e
−(jt)j
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Figure 1. Estimated survival curves for the neck and jaw using the control group data. The methods
used are Turnbull’s non-parametric estimator, a tted Weibull model and an exponential model.
for the treatment group, where  represents the eect of treatment on the hazard rate. We
assume here that the treatment eect is the same for each joint, and acts multiplicatively
on the marginal hazard rates. We denote the corresponding hazard functions by hj(t); h∗j (t),
respectively.
Assuming independent censoring, the contribution to the overall log-likelihood of a patient
in the control group is
‘ij(j; j; )=


log Sj(tij) if ij=0
log hj(tij) + log Sj(tij) if ij=1
log(1− Sj(tij)) if ij=2
and the rst and second derivatives are easily calculated, so that it is fairly straightforward to
estimate the Weibull parameters for each joint by maximum likelihood using only the control
group data. This was done by Rocke et al. [15], who found that some joints experienced
an apparently constant hazard rate (=1) whereas others had a hazard rate which increased
with age (¿1). The parameter estimates and their asymptotic standard errors are given in
Table I, together with the expected total number of joint failures in the treatment group during
the study, assuming no treatment eect, and the actual number of joint failures observed. The
expected values Nj are calculated by summing the reduction in Sj(t) over the treatment period
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Table I. Estimated Weibull parameters (standard errors in parenthesis) from the control group
(Rocke et al. [15]), with expected and observed joint failures for the treatment group.
Joint   Expected Observed
Neck 0.144 (0.026) 0.88 (0.11) 0 0
Spine 0.116 (0.018) 1.07 (0.14) 0 0
Jaw 0.042 (0.004) 2.32 (0.37) 1.41 0
Right shoulder 0.113 (0.016) 1.21 (0.16) 0.36 0
Right elbow 0.047 (0.007) 1.21 (0.18) 1.36 0
Right hip 0.052 (0.006) 1.62 (0.23) 1.17 0
Right knee 0.041 (0.003) 2.55 (0.37) 1.14 0
Left shoulder 0.123 (0.018) 1.14 (0.14) 0.91 0
Left elbow 0.038 (0.007) 1.14 (0.19) 1.34 1
Left hip 0.044 (0.007) 1.26 (0.20) 1.14 0
Left knee 0.037 (0.005) 1.59 (0.26) 1.28 1
for all joints uninvolved at the start of treatment, that is
Nj=
∑
i:tij¿si
[Sj(si)− Sj(tij)]
where si denotes the age of the ith patient at the start of treatment and Sj(·) is evaluated using
the estimated parameter values. Because the hazard rates are in general not constant, these
expected values incorporate information on the ages of the treatment group subjects as well
as the duration of their participation in the study and the status of each joint at recruitment.
The expected values are zero for the neck and spine because both of these joints had already
failed for all treatment group patients.
Where joints are in right–left pairs, it seems reasonable to assume that the parameters are
the same for each side; we can estimate these parameters by pooling the data for right and
left sides, thus allowing two observations per patient. Although some of the right and left
parameters in Table I seem to be dierent (in particular  for the knee joints), the pooling
results in a drop in the total log-likelihood of 4.17 on 8 d.f., which is not signicant. This test
is not really valid because it is based not on the true likelihood but the working likelihood
from the marginal model, which ignores the dependence between joints. However, assuming
that correlation is positive between right–left pairs, the above test will result in underestimated
p-values, so a valid test would also fail to reject. We assume in the subsequent analysis that
right–left pairs have the same parameters, and return to discuss this point further in the nal
section.
For the treatment group patients three times are relevant: the age si at the start of treatment;
the age ei at the end of the study, and the age tij at which the joint became involved. Here
we take the censoring variable ij to be 0 if the joint was still uninvolved after treatment, 1 if
involved during treatment and 2 if involved before treatment. The contribution to the overall
log-likelihood of a patient in the treatment group is
‘ij(j; j; )=


log S∗j (ei) + log Sj(si)− log S∗j (si) if ij=0
log h∗j (tij) + log S
∗
j (tij) + log Sj(si)− log S∗j (si) if ij=1
log(1− Sj(si)) if ij=2
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For example, if ij=1 then joint j survived without treatment until time si but failed during
treatment at time tij, the probability of this being
Sj(si)×
h∗j (tij)S
∗
j (tij)
S∗j (si)
For any given value of the treatment eect (for example, =1, corresponding to no ef-
fect) the Weibull parameters for a particular joint can now be estimated by maximum like-
lihood using the combined data from both treatment and control groups. If we assumed a
joint-specic treatment eect j it could also be estimated by maximum likelihood using the
marginal model for joint j. Since only two new joints became involved during treatment
(see Table I), the point estimate would in most cases be zero (that is, no hazard during
treatment). The small number of patients in the treatment group, together with the fact that
not all joints were initially uninvolved, means that no reliable inference about the treatment
eect can be made from considering a single joint, so we are forced to assume a common
 and therefore to perform a multivariate analysis. Since all patients in the treatment group
had both the neck and spine involved before the start of treatment, there is no informa-
tion about  in the data on these two joints so they may be omitted from the following
analysis.
3. INFERENCE FOR THE MARGINAL MODEL
Using the approach of Wei et al. [3] with our fully parametric model, we consider estimation
of the full parameter set =(; 1; 1; : : : ; J ; J )T by maximizing the working likelihood
L()=
∑
i
∑
j
‘ij(j; j; )
so that the estimator ˆ solves the estimating equation
∑
i; j
@
@T
‘ij(j; j; )=0
We note that here  has 11 components, corresponding to  and the Weibull parameters
for each joint type. The neck and spine data have been dropped, and the data on left=right
pairs pooled, so the number of joint types J=5. Assuming that the marginal models are
correct, the consistency of ˆ follows from a simple extension of the consistency argument of
Huster et al. [9]. Asymptotic normality follows from Huber [4] under mild regularity assump-
tions. The sandwich estimator of the covariance of ˆ is then given by
Vˆ =A−1U˜ TU˜A−1
where A is the observed information matrix
A=− @
2
@@T
L(ˆ)
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and U˜ is the ‘collapsed score matrix’ with 61 rows, one for each patient, and 11 columns.
The ith row of U˜ is
∑
j
@
@
‘ij ;
@
@1
‘i1;
@
@1
‘i1; : : : ;
@
@5
‘i5;
@
@5
‘i5
the rst element being zero for the 40 control group patients. A is block-diagonal apart from
the rst row=column. Specically the rst row is
∑
i
(∑
j
@2
@2
‘ij(ˆj; ˆj; ˆ);
@2
@1@
‘i1(ˆ1; ˆ1; ˆ); : : : ;
@2
@5@
‘i5(ˆ5; ˆ5; ˆ)
)
and the diagonal elements are the 2× 2 joint-specic information matrices I1; : : : ;I5 where
Ij=−
∑
i


@2
@2j
@2
@j@j
@2
@j@j
@2
@2j

 ‘ij(ˆj; ˆj; ˆ)
These are calculated routinely during the estimation of the Weibull parameters. The remaining
elements of A are zero. This structure occurs because ‘ij(j; j; ) does not depend on j′ , j′
for j′ = j.
We are interested only in the rst element vˆ11 which estimates the standard error of ˆ.
An approximate condence interval for  can now be constructed by assuming approximate
normality for ˆ. However this leads to a 95 per cent condence interval which includes
negative values, which is particularly unsatisfactory because we are most concerned with the
upper condence limit. This is caused by the fact that the (pseudo-) likelihood surface is
unsymmetrical with respect to . We can try to remedy this by reparameterizing the treatment
eect to give a more symmetrical likelihood surface. Transformation of  is easily incorporated
into the above analysis since the  derivatives can simply be adjusted using the chain rule.
We can investigate the eect of transformation on the likelihood surface by drawing the
prole log-likelihood
L()=
∑
j
max
j; j
∑
i
‘ij(j; j; )
for a range of values of . For  untransformed this prole log-likelihood graph is far from
symmetric, as can be seen in Figure 2(a). The natural transformation here would be to log 
since this removes the boundary =0; it is also the usual parameterization in the Cox model.
However the prole likelihood for log  is still far from symmetrical; in fact it errs in the
opposite direction to that of the untransformed  (Figure 2(b)). The problem here seems to
be that, as noted earlier, very few uninvolved joints became involved during treatment, and
it is only these which prevent ˆ from being zero. To apply the robust variance estimator
in constructing a condence interval, we seek a transformation which will approximately
symmetrize the prole log-likelihood. In Figure 2(c) we show the prole log-likelihood for
the 0.5 power, and in Figure 2(d) we show the plot for 0.3, which appears to be a suitable
choice.
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Figure 2. Eect of transformation of the treatment eect parameter on the shape of the
prole likelihood: (a) untransformed prole likelihood; (b) logarithmic transformation;
(c) 0.5 power; (d) 0.3 power.
An alternative consideration of the shape of the likelihood surface is obtained by allowing
 to vary while keeping the other parameters xed. Because there are no left-censored obser-
vations during treatment, the second partial derivative with respect to  of the log-likelihood
is −nT=2 where nT is the number of observed events during treatment. It follows by appli-
cation of the chain rule that the third derivative vanishes at the maximum when a cube-root
transformation is used. (This result holds for any proportional hazards model with only right-
censoring.) This is in broad agreement with the graphical approach using the prole likelihood.
Using the cube-root transformation and applying the chain rule to the above robust variance
methodology, we arrive at the 95 per cent condence interval for  of (0:008; 0:497), or a
reduction in the hazard of new joint involvement of between 50 and 99 per cent.
The point estimate is ˆ=0:117. Table II gives the point estimates and standard errors for
the joint-specic Weibull parameters, together with the expected and observed numbers of
joint failures for both control and treatment groups. For the treatment group we give expected
and observed counts before and during the treatment period, based on the estimated Weibull
parameters and treatment eect. It is noticeable that the number of involved joints in this
group prior to treatment is in all cases greater than that predicted by the model, suggesting
that there may be a systematic dierence between the groups. We postpone discussion of
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Table II. Estimated Weibull parameters (standard errors in parenthesis) from the marginal model, with ex-
pected (observed) joint failures for the control group and the treatment group before and during treatment.
Joint   Control Before During
Neck 0.181 (0.033) 0.85 (0.13) 36.5 (37) 16.5 (21) 0.32 (0)
Spine 0.149 (0.022) 0.99 (0.15) 36.0 (35) 15.9 (21) 0.37 (0)
Jaw 0.043 (0.003) 2.05 (0.36) 25.4 (26) 5.6 (6) 0.26 (0)
Shoulders 0.136 (0.018) 1.09 (0.15) 71.4 (74) 31.0 (36) 0.82 (0)
Elbows 0.044 (0.006) 1.11 (0.13) 50.5 (52) 15.8 (16) 0.49 (1)
Hips 0.060 (0.006) 1.19 (0.21) 58.3 (59) 19.6 (29) 0.62 (0)
Knees 0.041 (0.003) 1.81 (0.23) 49.0 (50) 11.2 (14) 0.49 (1)
this until Section 5. We also note that if the expected number of joint involvements during
treatment is calculated conditional on the observed number of failures prior to treatment, these
become 0.19, 0.22, 0.36, 0.29, 0.35.
To investigate the validity of the robust variance approach, which is based on an asymptotic
approximation, we simulated new data sets using the estimated parameter values of our model,
keeping the same censoring times (that is, the ages of patients at interview, or start and end
of treatment). To simulate correlated Weibulls with the given marginals we started with
11-dimensional standard normals, transformed these to equicorrelated normals, squared and
added pairs to give correlated 11-dimensional exponentials, and then used the joint-specic
parameters to convert the components to Weibulls. The degree of correlation is controlled
by the o-diagonal element r in the matrix used to transform the standard normals, the
correlation in the transformed normals being (2r+9r2)=(1+10r2). Values of 0.1, 0.2, 0.3, 0.4
give correlations of 0.26, 0.54, 0.74, 0.86, respectively, thus ranging from fairly weak to quite
strong correlation between the within-patient joint failure times. Based on 5000 simulations
each, we found that the rates of inclusion of the true value of  of nominal 95 per cent
condence intervals, using robust variance with the cube-root transform, were 95.7, 93.5,
91.4 and 90.4 per cent, respectively. Thus there appears to be a deterioration in performance
as the strength of the correlation increases. To match the actual data to the simulation results
we estimated within-patient correlations using the observed failure times and matched these
informally with the correlations in the simulated data, which suggested that our data are
closest to r=0:3. Thus our 95 per cent interval is perhaps closer to 90 per cent in coverage.
The averages of the robust standard errors of the cube-root transformed treatment eect for
each set of simulations were, respectively, 0.0847, 0.0845, 0.0849, 0.0862; the corresponding
standard deviations of the point estimates were 0.0852, 0.0883, 0.0923, 0.0968. This seems to
suggest that some form of parametric bootstrap might be a better procedure, but this would
require a parametric model of the dependence. Moreover, neither the parametric nor the non-
parametric bootstrap will work with our data because many of the bootstrap samples have
no observed failures on treatment, resulting in an innite estimated treatment eect (ˆ=0).
Thus the use of the asymptotic robust variance, while not ideal, would seem to be the only
tractable method, and is greatly improved by the cube-root transform.
4. FRAILTY MODEL
Here we take the hazard rate for patient i to be of the form hi(t)=Zih0(t) where h0(t) is
a baseline hazard which might depend on covariates such as, in our case, treatment with
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Accutane. The frailties {Zi} are usually assumed to come from a parametric family of dis-
tributions, for example the gamma distribution with mean 1. This gamma family is often
convenient for estimation via the EM algorithm, the frailties being regarded as unobserved
data. If the Cox partial likelihood is used, the frailties Zi enter linearly into that part of the
log-likelihood which depends on the regression and gamma parameters, and the conditional
expectation of each Zi is also easy to calculate.
In the presence of double-censoring, however, this convenience is lost. There is no partial
likelihood, and the left-censoring introduces terms of the form (1 − e−ZiHij(; t)) into the full
likelihood so that the EM algorithm becomes intractable. When the terms for the ith person are
multiplied out we get the sum of terms of the form Znii e
−ZiKij(; t), so the assumption of a gamma
distribution still allows the frailties to be integrated out of the likelihood reasonably simply.
However the resulting function is extremely complex in its dependence on the regression
parameters  and the baseline survivor functions, so for highly multivariate problems such as
ours a direct maximization of the likelihood is again intractable. Our approach instead is to
use the conditional independences in the model as much as possible, iteratively estimating the
frailties Zi and the survivor function parameters j; j to maximize the complete likelihood
for each value of the parameters of interest, and to base inferences on these parameters on
the resulting prole likelihood.
Frailties are easily incorporated into our model, the survival function for an individual with
frailty Zi becoming
Sj(t|Zi)=
{
e−Zi(jt)
j in the control group
e−Zi(jt)
j in the treatment group
(1)
The treatment eect is here assumed to have a multiplicative eect on the conditional hazards
hj(t|Zi).
Our approach to the treatment of the frailties is similar to that used by McGilchrist and
Aisbett [17] to t a frailty model to bivariate catheter infection data. They rst consider the
frailties to be xed eects, which they estimate together with a regression parameter  by
maximizing the log-likelihood L(z; ) subject to the constraint
∑
log(Zi)=0. They use the
Cox model so their log-likelihood comes from the Cox partial likelihood. They then consider
an alternative random eects model in which the log frailties are Gaussian with zero mean
and unknown variance. They construct a ‘penalized likelihood’ by augmenting the previous
log-likelihood of the observations with z conditionally xed by the likelihood of z as given
by the log-normal frailty distribution. This is again maximized subject to the same constraint
on the vector z of frailties. This second alternative can be thought of as a hierarchical model
in which the log Zi for each patient is rst chosen from N(0; 2) and then the observations
arise from the conditional distributions given Zi. This approach is generally preferred because
direct maximization over a large number of nuisance parameters as in the rst method is
likely to produce inconsistent estimates.
Taking the rst approach, in which the Zi are regarded as xed eects, our model gives
the log-likelihood as
L(; z; )=
∑
i
∑
j
‘ij(; Zi; j; j)
where z is the vector of frailties and  the vector of Weibull parameters. Inference for  can
be based on the prole likelihood [18]; for each xed  we maximize the above expression
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over z; . There is an identiability problem since we can replace z by kz and j by (j=k)1=j
for any positive scalar k without changing the likelihood, so we impose
∑
log(Zi)=0. To
achieve the optimization we use the following iterative scheme:
1. Initialize Zi≡ 1.
2. For each joint type j calculate the conditional maximum likelihood estimates for the
Weibull parameters j; j given z by maximizing
∑
i ‘ij(; Zi; j; j).
3. For each subject i calculate the conditional maximum likelihood estimate for Zi given
 by maximizing
∑
j ‘ij(; Zi; j; j).
4. Adjust z to satisfy the constraint, multiplying each Zi by e−
∑
i log(Zi)=n.
5. Repeat steps 2–4 until convergence.
We note that step 4 is not necessary for convergence but is necessary for identiabil-
ity of the model. By using alternating conditional maximum likelihood estimators we are
able to replace a complex multiparameter optimization by a number of simpler univari-
ate and bivariate ones. Repetition over a range of values of  can be expedited by us-
ing the nal z and  from the previous  as starting values for the next. The estimate
is ˆ=0:031, and using the usual asymptotic 2 approximation to the logged likelihood ra-
tio gives the 95 per cent condence interval (0:005; 0:098). Each prole likelihood calcu-
lation also yields estimates of the frailties z of the individuals in the study. The obvious
approach here would be to use the estimates of z at the maximizing values of  and .
These might be of some clinical interest, but the estimates are likely to be unreliable be-
cause of the large number of parameters involved. Figure 3 shows kernel-smoothed den-
sity estimates for these estimated log frailties, separately for each group. There is again
some suggestion of a dierence between the control and treatment groups, to be discussed in
Section 5.
Turning now to the second approach, we consider a hierarchical model in which the Zi are
random drawings from some ‘frailty distribution’. Figure 3 suggests that the log frailties are
approximately normal, so we follow McGilchrist and Aisbett [17] in using penalized likelihood
with a log-normal distribution, but dier slightly in that we consider the Zi to be independent
of each other, whereas they specify a multivariate distribution for z which incorporates the
constraint
∑
log(Zi)=0. This constraint is no longer necessary for identiability because of
the penalty term, but it will be satised by the maximum likelihood estimates. We therefore
continue to impose the constraint, not as part of the model but as part of the estimation
procedure.
Our main focus of interest is again , but it may also be relevant to examine the ‘frailty pa-
rameter’ . For xed (; ) we maximize the likelihood over the Weibull and
frailty parameters following steps 1–5 to give the ‘penalized prole likelihood’
LP(; )= max
; ; z
{∑
j
‘ij(; Zi; j; j)− 61 log  − (log Zi)
2
22
}
Evaluating this over a grid of values allows examination of the likelihood surface, as in
Figure 4, which shows max; LP(; )−LP(; ); the contour corresponding to level 3 is an
approximate asymptotic 95 per cent condence region. This suggests that log  is signicantly
less than zero, pointing again to a signicant reduction in hazard with Accutane use. The
point estimate for (; ) is (0.059, 0.94).
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Figure 4. Penalized prole likelihood for the treatment and frailty parameters in the frailty model.
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5. TESTING FOR GROUP DIFFERENCES
The above analysis assumes that the treatment and control groups are comparable, in that they
have the same baseline survival functions in the marginal model or the same frailty distribution
in the frailty model. Since the allocation was not done on the basis of a randomized trial, there
may be systematic dierences between the groups which would aect and perhaps invalidate
our inference about the treatment eect. We have noted two possible sources of bias: dierent
recruitment criteria and dierent diagnosis of joint involvement. The second of these could
perhaps be accommodated by arguing that the more sensitive radiographical diagnosis applied
to the treatment group would tend, if anything, to diminish the apparent eectiveness of the
treatment, but little can be said about the rst. Furthermore there may be omitted covariates
causing a dierence between groups.
We saw in the tted marginal model, from Table II, that the treatment group had a higher
than expected number of joint involvements prior to the commencement of the treatment
period, particularly in the neck and spine regions. Since these were determined by radiological
scans it is possible that in many cases immobilization of the joint had not yet occurred, so
that some of these would not be classed as involved using the control group criterion.
It was noted in Section 4 that the frailty analysis suggests, from Figure 3, that there is a
systematic dierence between the groups, with the treatment group having higher frailties than
the control group: this eect, though reduced, still exists when a parametric family is used
to model the frailties. This again is consistent with the more sensitive diagnostic techniques
used in the clinical examinations. These dierences are incorporated into the estimation of
the treatment eect; if we eliminated the dierence by forcing the log frailties to sum to zero
separately for each group, this would then reduce the estimated frailties for the treatment
group and hence reduce the apparent eectiveness of the treatment. It might be better in such
situations to assume dierent distributions for the frailties in the control and treatment groups.
It should be noted that since the treatment is time-dependent, with some information avail-
able on the treatment patients before their treatment began, it would be possible to estimate 
using only this group. This does not work well in practice because there are only 21 subjects
and nearly all the observations are either right- or left-censored. We can however use this pre-
treatment information to examine possible dierences between the groups. Using the marginal
model approach we can subsume any recruitment, diagnostic and covariate dierences into a
single group dierence parameter 	, assumed to have a multiplicative eect on the marginal
hazard rates for the treatment group. Proceeding as before, we use a working independence
model to estimate 	. The contributions to the working log-likelihood for the ith treatment
group patient are now
‘ij(j; j)=
{
	 log Sj(si) if ij=0
log(1− [S(si)]	) if ij=2
with all observations being either left- or right-censored according to their status at the time of
commencement of the treatment period. This gives 	ˆ=1:84 so the pre-treatment information
suggests that if anything the treatment group are more prone to joint involvement than the
controls at baseline, perhaps because of the more sensitive radiological diagnosis. This would
tend to strengthen our conclusions about the eectiveness of the Accutane treatment. However
the robust variance estimate gives the standard error of 	ˆ as 0.81, and the prole likelihood
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for the untransformed parameter is reasonably symmetric, so the estimated group dierence is
not signicantly dierent from 	=1. It seems reasonable then, given the limited information
available, to proceed with the assumption of no group dierences.
6. DISCUSSION
We have considered two dierent methods of trying to accommodate the within-patient de-
pendence in multivariate survival analysis. Both approaches are suciently common in the
literature to be considered standard (see for example Klein and Moeschberger [19]), but until
now both the application and much of the theory has used partial likelihood in the Cox model.
When there is double censoring, considerable adaptation is required. In particular there seems
now to be no alternative to the estimation of the baseline survival functions, which brings
both computational and inferential diculties. These diculties are further increased when we
move from bivariate data, which has been the norm in the literature, to highly multivariate
data (p=11). Here we have taken a parametric approach to the modelling of the survival
functions, but adapting it to a semi-parametric model in which the survivor functions are
estimated non-parametrically would be very challenging. We have also had to assume that
the treatment eect, and the frailties in the frailty model, are the same for each joint. Ideally
one would want to check these assumptions, but given the sparsity of our data we have been
unable to do so. The elbow and knee joints had one failure each during treatment, leading to
condence intervals of (0.015, 1.03) and (0.019, 1.09), respectively. It is clear from these that
there is not enough data on individual joint failures to estimate and compare joint-specic
treatment eects. There seems no alternative to the assumption that the eect of Accutane
is homogeneous. We have noted that both joint failures aected the same patient. While it
may be extreme to suppose that only this patient received no protection from Accutane, it
is probably also extreme to suppose that Accutane protects every patient equally. Again we
found no tractable alternative to the strong assumption made.
The most important conclusion is shared by both the marginal and frailty approaches;
Accutane treatment leads to a signicant reduction in the rate of involvement of previously
unaected joints. It is important to note however that the two approaches lead to dierent
interpretations of the treatment eect, and to dierent marginal distributions for the joint
involvements. The marginal model assumes that Accutane has the same multiplicative eect on
each of the marginal hazard rates, and that the marginal distributions are Weibull. The frailty
model assumes that Accutane has the same multiplicative eect on each of the conditional
hazard rates of an individual given their frailty, and that the conditional distributions are
Weibull. If we were to integrate out the frailty we would nd that the marginal distributions
were not Weibull, and that the eect of Accutane was not proportional on the marginal
hazard. Since the Weibull model was originally chosen by examining the marginal distributions
(Section 2), we might want to question the parametric forms used in the frailty model. The
log-normal frailty distribution was chosen by examining the unrestricted frailty estimates,
but other choices could have been made. The gamma distribution is a common choice, but
its convenience is lost with double censoring. Hougaard [20] recommends a positive stable
distribution since this preserves proportional hazards in the margins.
Both approaches as implemented here involve a large number of nuisance parameters, which
given the small amount of data must raise concerns about the asymptotic results used. This
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is particularly true for the frailty model. With the frailties as xed parameters there are in all
76 parameters and 671 observations. It is clearly preferable to regard the frailties as random
eects, and the penalized likelihood approach does this, although ideally one would want to
integrate the frailties out of the likelihood. This seems to be intractable with doubly-censored
data. We have made some savings on the number of parameters by assuming that right–
left pairs of joints have the same baseline hazards; that is, the same Weibull parameters. In
Table II the  parameters seem dierent for the hip and especially the knee joints, although
these parameter values are not precise as evidenced by the large standard errors. Ideally we
would like to test simultaneously the equality of all eight pairs of parameters, but the usual
likelihood ratio test does not apply because it ignores within-patient correlation. A referee has
suggested that dierences between pairs might explain the lack of t for hip in the treated
group (Table II). However, the 29 pre-treatment failures comprise 14 left and 15 right hips.
The lack of t in this column is evidence that the treatment group appear to be more frail,
as discussed in Section 5. That this frailty seems particularly pronounced for the hip joints is
an interesting observation, but not one that we can explain.
An advantage of the marginal approach is that it applies without our having to specify the
type of dependence between joints. The frailty model assumes that these are conditionally
independent given the frailty, which may not be a reasonable assumption; although the mech-
anism is not known, some clinicians believe that the disease progresses in a characteristic
pattern [2; 21]. The frailty model approach is, however, of added interest since it provides
(through the frailty parameter ) information about the range of dierences in the severity of
the disease which might be useful to clinicians; estimates of individual frailties could also be
helpful in predicting prognosis for individual patients.
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